PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA.
Stutterheim J, et al.
J Clin Oncol. 2008 Nov 20;26(33):5443-9. doi: 10.1200/JCO.2007.13.6531. Epub 2008 Oct 6.
J Clin Oncol. 2008.
PMID: 18838715